37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin

37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin structure

CAS No.: 98813-12-8

Chemical Name:: 37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin

Synonyms: Bafilomycin E;37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin;[3,9-dihydroxy-10-[(4Z,6Z,12Z,14E)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]-2,4,8-trimethyl-7-oxoundecan-5-yl] (E)-4-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-4-oxobut-2-enoate;2-Butenoic acid, 4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-, (1R,4S,5R,6S)-5-hydroxy-6-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-[(1S,2R)-2-hydroxy-1,3-dimethylbutyl]-4-methyl-3-oxoheptyl ester, (2E)-

CBNumber:: CB82318769

Molecular Formula:: C44H65NO13

Molecular Weight:: 815.99

MDL Number:

MOL File:: 98813-12-8.mol

Request For Quotation

37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin Properties

Boiling point	991.3±65.0 °C(Predicted)
Density	1.20±0.1 g/cm3(Predicted)
pka	3.68±0.30(Predicted)

37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin Preparation Products And Raw materials

Raw materials

Preparation Products

37-De(carboxy)-19,23-O-seco-2-demethyl-19,23-dideoxy-23-hydroxy-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-19-oxohygrolidin Bafilomycin E [3,9-dihydroxy-10-[(4Z,6Z,12Z,14E)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]-2,4,8-trimethyl-7-oxoundecan-5-yl] (E)-4-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-4-oxobut-2-enoate 2-Butenoic acid, 4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-, (1R,4S,5R,6S)-5-hydroxy-6-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-[(1S,2R)-2-hydroxy-1,3-dimethylbutyl]-4-methyl-3-oxoheptyl ester, (2E)- 98813-12-8